532523:BOM
Biocon Ltd
350,00 ₹
arrow_downward
-0,43%(-1,50) 1 d.
16. okt., 15:30:00 GMT+5:30 · INR
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: 532523…
Atvērt
352,95 ₹
Augsta
352,95 ₹
Zema
348,10 ₹
Tirgus kapitalizācija
568,79 mljrd.
Vid. apjoms
692,61 tūkst.
Apjoms
668,34 tūkst.
Dividende
0,14%
Ceturkšņa dividendes
0,13 ₹
Datums, kad tiek pārtraukta dividenžu izmaksa
2026. gada 3. jūl.
Cenas/peļņas attiecība
103,62
Augstākā 52 ned.
447,00 ₹
Zemākā 52 ned.
337,95 ₹
Peļņa uz vienu akciju
3,38 ₹
Apgrozībā esošās akcijas
600,00 milj.
Darbinieku skaits
16 tūkst.
Atvērt
352,95 ₹
Augsta
352,95 ₹
Zema
348,10 ₹
Tirgus kapitalizācija
568,79 mljrd.
Vid. apjoms
692,61 tūkst.
Apjoms
668,34 tūkst.
Dividende
0,14%
Ceturkšņa dividendes
0,13 ₹
Datums, kad tiek pārtraukta dividenžu izmaksa
2026. gada 3. jūl.
Cenas/peļņas attiecība
103,62
Augstākā 52 ned.
447,00 ₹
Zemākā 52 ned.
337,95 ₹
Peļņa uz vienu akciju
3,38 ₹
Apgrozībā esošās akcijas
600,00 milj.
Darbinieku skaits
16 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
Simply Wall Street
·
pirms 42 minūtēm
Freshworks (FRSH) Shares Just Moved, So What Is Going On?
KuCoin
·
pirms 32 minūtēm
Nasdaq posts its worst weekly decline since June, gold rebounds but faces resistance at 4200
Yahoo Finance
·
pirms 14 stundām
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
MarketWatch
·
pirms 1 dienas
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profils
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Par “Biocon Ltd”
ĢenerāldirektorsShreehas P Tambe
Darbinieki16,4 tūkst.
Dibināšanas datums1978. gada 29. nov.
Galvenais birojsBengalūru, Karnātaka, Indija
Sektors-
Tīmekļa vietnebiocon.com